Investors Buy Express Scripts (ESRX) on Weakness Following Insider Selling
Investors purchased shares of Express Scripts Holding (NASDAQ:ESRX) on weakness during trading hours on Tuesday following insider selling activity. $87.42 million flowed into the stock on the tick-up and $71.77 million flowed out of the stock on the tick-down, for a money net flow of $15.65 million into the stock. Of all companies tracked, Express Scripts had the 31st highest net in-flow for the day. Express Scripts traded down ($0.57) for the day and closed at $72.42Specifically, VP Glen D. Stettin sold 3,449 shares of the business’s stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $81.00, for a total transaction of $279,369.00. Following the completion of the transaction, the vice president now owns 33,715 shares in the company, valued at approximately $2,730,915. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Glen D. Stettin sold 3,448 shares of the business’s stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $76.00, for a total transaction of $262,048.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 31,681 shares of company stock valued at $2,435,102. 0.68% of the stock is currently owned by company insiders.
Several research analysts recently commented on ESRX shares. Deutsche Bank initiated coverage on shares of Express Scripts in a research note on Monday, December 4th. They set a “buy” rating and a $75.00 price objective for the company. ValuEngine upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, December 4th. TheStreet upgraded shares of Express Scripts from a “c+” rating to a “b-” rating in a research note on Monday, December 4th. Sanford C. Bernstein upgraded shares of Express Scripts from an “underperform” rating to a “market perform” rating in a research note on Wednesday, December 6th. Finally, BidaskClub upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Thursday, December 14th. Three analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and six have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $81.97.
The firm has a market cap of $40,964.68, a price-to-earnings ratio of 9.15, a P/E/G ratio of 0.89 and a beta of 0.94. The company has a current ratio of 0.67, a quick ratio of 0.55 and a debt-to-equity ratio of 0.83.
Express Scripts announced that its board has approved a stock repurchase plan on Monday, December 18th that allows the company to repurchase 45,000,000 outstanding shares. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its shares are undervalued.
Hedge funds have recently added to or reduced their stakes in the company. SeaCrest Wealth Management LLC purchased a new stake in shares of Express Scripts in the 4th quarter valued at $105,000. Bank of Nova Scotia Trust Co. purchased a new stake in shares of Express Scripts in the 3rd quarter valued at $120,000. Aevitas Wealth Management Inc. purchased a new stake in shares of Express Scripts in the 4th quarter valued at $128,000. Financial Gravity Companies Inc. purchased a new stake in shares of Express Scripts in the 4th quarter valued at $142,000. Finally, Monroe Bank & Trust MI boosted its holdings in shares of Express Scripts by 74.8% in the 3rd quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after acquiring an additional 970 shares during the last quarter. 89.44% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This piece was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.watchlistnews.com/investors-buy-express-scripts-esrx-on-weakness-following-insider-selling/1954630.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.